-
Posted by
Two Blokes Jun 15 -
Filed in
Stock
-
5 views
Sarepta Therapeutics on Sunday said there had been a second reported case of acute liver failure resulting in death after a patient received the company's gene therapy for a rare form of muscular dystrophy.